enow.com Web Search

  1. Ads

    related to: eosinophilic asthma medication list

Search results

  1. Results from the WOW.Com Content Network
  2. Reslizumab - Wikipedia

    en.wikipedia.org/wiki/Reslizumab

    Reslizumab was first used for eosinophilic asthma in 2008. In a 106-patient, phase II clinical trial , the researchers showed reslizumab was effective in reducing sputum eosinophils. Furthermore, the patients receiving reslizumab showed improvements in airway function, and a general trend toward greater asthma control than those receiving ...

  3. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

  4. Mepolizumab - Wikipedia

    en.wikipedia.org/wiki/Mepolizumab

    Mepolizumab, sold under the brand name Nucala by GlaxoSmithKline, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome (HES). [5] It recognizes and blocks interleukin-5 (IL-5), a signalling protein of the immune system.

  5. If You're Living With Asthma, Here's Every Single Treatment ...

    www.aol.com/lifestyle/youre-living-asthma-heres...

    The most common class of quick-relief asthma medications is known as bronchodilators. These meds work by relaxing the smooth muscles that line your airways. During an asthma attack, the muscles ...

  6. GSK's experimental drug shows promise in reducing severe ...

    www.aol.com/news/gsks-experimental-drug-shows...

    The drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for patients with eosinophilic asthma, GSK said on Tuesday. This form of asthma is characterised by ...

  7. Benralizumab - Wikipedia

    en.wikipedia.org/wiki/Benralizumab

    It was developed by MedImmune for the treatment of asthma. It is currently marketed by Astrazeneca. [3] [4] Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016. [5] [6] It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe eosinophilic asthma. [7]

  1. Ads

    related to: eosinophilic asthma medication list